César Pacheco‐Tena

4.0k citations
90 papers · 1.9k · 1 hit paper · h-index 22

Impact in

  • Rheumatology top 0.5%
    • Rheumatoid Arthritis Research and Therapies
    • Spondyloarthritis Studies and Treatments
    • Systemic Lupus Erythematosus Research
  • Hematology top 2%
    • Autoimmune and Inflammatory Disorders Research

Papers in

    • Rheumatoid Arthritis Research and Therapies 45
    • Spondyloarthritis Studies and Treatments 34
    • Systemic Lupus Erythematosus Research 14
    • Autoimmune and Inflammatory Disorders Research 35

César Pacheco‐Tena

84 papers receiving 1.9k citations

César Pacheco‐Tena's Hit Papers

Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis 2021 · 182 citations
1820+1+3Years since publication50100150

Peers

César Pacheco‐Tena
Comparison fields: 5 of 125
  • Rheumatology 1.2k
  • Hematology 556
  • Immunology 607
  • Periodontics 48
  • Pharmacology 84
Replace Paola Conigliaro with:
Paola Conigliaro Italy
Paola Triggianese Italy
M. Kristen Demoruelle United States
Hoon‐Suk Cha South Korea
George Nuki United Kingdom
Luisa Costa Italy
Steven E. Carsons United States
Arthur Kavanaugh United States
D. Alpizar-Rodriguez Switzerland
Jeng‐Hsien Yen Taiwan
César Pacheco‐Tena relative to Paola Conigliaro Italy Paola Conigliaro's profile →
Citations per field
00.5×1.5×1.8×
Paola Conigliaro · 1×
Citations per year

Countries citing papers authored by César Pacheco‐Tena

Since Specialization
Citations

This map shows the geographic impact of César Pacheco‐Tena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by César Pacheco‐Tena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites César Pacheco‐Tena more than expected).

Fields of papers citing papers by César Pacheco‐Tena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by César Pacheco‐Tena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by César Pacheco‐Tena. The network helps show where César Pacheco‐Tena may publish in the future.

Co-authors

The 25 scholars most cited alongside César Pacheco‐Tena, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with César Pacheco‐Tena Line = papers co-authored together César Pacheco‐Tena links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2016262
2
Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis
Hit paper breakdown →
2021182
3 2018149
4 2016117
5 2015107
6
Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity.
200390
7 199767
8
Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies.
200461
9 202158
10 200157
11
A proposal for the classification of patients for clinical and experimental studies on reactive arthritis.
199948
12 200637
13 201837
14
Assessment of different decalcifying protocols on Osteopontin and Osteocalcin immunostaining in whole bone specimens of arthritis rat model by confocal immunofluorescence.
201332
15
Intradermal tophi in gout: a case-control study.
199932
16 201731
17 200426
18 201423
19
A short-term follow-up of enthesitis and arthritis in the active phase of juvenile onset spondyloarthropathies.
200323
20 200422

About César Pacheco‐Tena

César Pacheco‐Tena is a scholar working on Rheumatology, Hematology, Immunology, Epidemiology and Molecular Biology, having authored 90 papers that have together received 1.9k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (45 papers), Autoimmune and Inflammatory Disorders Research (35 papers), Spondyloarthritis Studies and Treatments (34 papers), Systemic Lupus Erythematosus Research (14 papers), Psoriasis: Treatment and Pathogenesis (9 papers), Musculoskeletal Disorders and Rehabilitation (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Inflammatory Bowel Disease (5 papers). The work is most often cited by research in Rheumatology (1.2k citations), Hematology (556 citations), Immunology (607 citations), Periodontics (48 citations) and Pharmacology (84 citations). César Pacheco‐Tena has collaborated with scholars based in Mexico, Colombia and United States. Frequent co-authors include Susana Aideé González‐Chávez, Celia María Quiñonez-Flores, Rubén Burgos‐Vargas, Janitzia Vázquez‐Mellado, Robert D. Inman, Millicent Stone, Mark C. Genovese, Paul R. Fortin, Ronald van Vollenhoven and Nils Kinnman. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Rheumatology, Scientific Reports, RMD Open and Journal of Immunology Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact